(Q34044762)

30 July 2017

1 reference

title

Postmenopausal osteoporosis. Strategies for preventing bone loss, avoiding fracture (English)

1 reference

30 July 2017

0 references

K A McGarry

1

1 reference

30 July 2017

D P Kiel

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

30 July 2017

published in

Postgraduate Medicine

1 reference

30 July 2017

volume

108

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

79-82, 85-8, 91

1 reference

Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.09.1.1206

The socioeconomic burden of fractures: today and in the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.09.1.1206

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.09.1.1206

Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.09.1.1206

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.09.1.1206

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.09.1.1206

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.09.1.1206

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.09.1.1206

Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.09.1.1206

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.09.1.1206

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.09.1.1206

Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. Fracture Intervention Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.09.1.1206

The effect of postmenopausal estrogen therapy on bone density in elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.09.1.1206

Increments in Bone Mineral Density of the Lumbar Spine and Hip and Suppression of Bone Turnover Are Maintained after Discontinuation of Alendronate in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.09.1.1206

10.3810/PGM.2000.09.1.1206

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference